CLASS II Device recall · Reported 17 Feb 2021 · FDA Enforcement Report

Aquarius LPH 511-A CRLF2 Distal Probe Green recalled by Cytocell

Cytocell is recalling Aquarius LPH 511-A CRLF2 Distal Probe Green, distributed in 7 states. The recall was initiated on 22 Dec 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots 072240, 071390, and 072693
Quantity recalled72

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1099-2021
FDA event ID
87090
Recalling firm
Cytocell, Cambridge, N/A
Classification
Class II
Status
Terminated
Recall initiated
22 Dec 2020
FDA classified
8 Feb 2021
Reported
17 Feb 2021
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

22 Dec 2020Recall initiated by company
8 Feb 2021Classified by FDA+48 days
17 Feb 2021Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that utilizes the LPH511-A CRLF2 Distal Probe Green.

Product as listed by the FDA

Aquarius LPH 511-A CRLF2 Distal Probe Green, model no. LPH 511-A The CRLF2 Distal probe, labelled in green, consists of two probes (71kb and 131kb) that are situated distal (telomeric) to the CRLF2 gene

Where it was distributed

Domestic distribution to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington. Foreign distribution to Canada.

CaliforniaIllinoisMichiganMinnesotaNew JerseyTexasWashington

Questions about this recall

Is Aquarius LPH 511-A CRLF2 Distal Probe Green recalled?

Yes. Cytocell recalled Aquarius LPH 511-A CRLF2 Distal Probe Green on 22 Dec 2020. The recall is Class II and its status is Terminated. Recall number Z-1099-2021.

Why was it recalled?

Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that utilizes the LPH511-A CRLF2 Distal Probe Green.

Which lots are affected?

Lots 072240, 071390, and 072693

Where was it sold?

Domestic distribution to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington. Foreign distribution to Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cytocell

All 14

Other Other Medical Devices recalls

All 13,778